A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

Abroad (travel likely)RecruitingPHASE2

Conditions

Smoking

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Woodland Research Northwest, Rogers, Arkansas, United States

    Contact: Principal Investigator (Timothy Cook)
  • Hillcrest Medical Research, DeLand, Florida, United States

  • TecTum Research, Hollywood, Florida, United States

    Study coordinator · 954-990-7649
    Contact: Principal Investigator (Juan Rondon)
  • K2 Medical Research ORLANDO, Maitland, Florida, United States

    Study coordinator · 407-500-5252
    Contact: Principal Investigator (Brandon Lenox)
  • GTL Medical & Research Group, Miami, Florida, United States

    Contact: Principal Investigator (Dunia Llapur Hernandez)
  • North Georgia Clinical Research, Woodstock, Georgia, United States

    Study coordinator · 678-494-5735
    Contact: Principal Investigator (Bram Wieskopf)
  • Revival Research Institute, LLC, Dearborn, Michigan, United States

    Study coordinator · 586-276-7453
    Contact: Principal Investigator (Abdulhassan Saad)
  • Arch Clinical Trials, St Louis, Missouri, United States

    Contact: Principal Investigator (Kulsoom Junaid)
  • Vector Clinical Trials, Las Vegas, Nevada, United States

    Study coordinator · 702-750-0000
    Contact: Principal Investigator (Ann Childress)
  • Rochester Clinical Research, LLC, Rochester, New York, United States

    Study coordinator · 585-288-0890
    Contact: Principal Investigator (Leigh Schirmer)
  • Coastal Carolina Research Center, North Charleston, South Carolina, United States

    Study coordinator · 843-352-6977
    Contact: Principal Investigator (Rica Santiago)
  • Circle Clinical Research, Sioux Falls, South Dakota, United States

    Study coordinator · 605-215-1159
    Contact: Principal Investigator (Sophie Two Hawk)
  • FutureSearch Trials of Dallas, Dallas, Texas, United States

    Study coordinator · 214-369-2600
    Contact: Principal Investigator (Michael Downing)
  • The University of Texas Health Science Center at Houston, Houston, Texas, United States

    Study coordinator · 832-776-3151
    Contact: Principal Investigator (Luba Yammine)
  • Health Research of Hampton Roads, Inc., Newport News, Virginia, United States

    Study coordinator · 757-591-8100
    Contact: Principal Investigator (George Freeman)
  • Eastside Research Associates, Redmond, Washington, United States

    Study coordinator · 425-869-6828
    Contact: Principal Investigator (Chad Crystal)
  • Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    Contact: Principal Investigator (Lirong Liang)
  • Beijing Anding Hospital - Affiliated Capital University of Medical Science, Beijing, China

    Contact: Principal Investigator (Anning Li)
  • Sichuan Provincial People's Hospital, Chengdu, China

    Contact: Principal Investigator (Haiying Yan)
  • 2nd Affiliated Hospital Chongqing Medical University, Chongqing, China

    Study coordinator · 13452414579
    Contact: Principal Investigator (Na Li)
  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China

    Contact: Principal Investigator (Jinsong Tang)
  • Taizhou Hospital of Zhejiang Province, Linhai, China

    Contact: Principal Investigator (Dongqing LV)
  • The first affiliated hospital of Ningbo university, Ningbo, China

    Contact: Principal Investigator (Yunxin Ji)
  • The University of Hong Kong-Shenzhen Hospital, Shenzhen, China

    Contact: Principal Investigator (Lei Rong)
  • Miyazaki RC Clinic, Shinagawa-ku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Masaki Miyazaki)
  • Samoncho Clinic, Shinjuku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takahiro Yokoyama)
  • Higashi Shinjuku Clinic, Tokyo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hiroaki Kondo)
Study leads
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company